Adjuvants in Veterinary Vaccines: Modes of Action and Adverse Effects

169Citations
Citations of this article
179Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Vaccine adjuvants are chemicals, microbial components, or mammalian proteins that enhance the immune response to vaccine antigens. Interest in reducing vaccine-related adverse effects and inducing specific types of immunity has led to the development of numerous new adjuvants. Adjuvants in development or in experimental and commercial vaccines include aluminum salts (alum), oil emulsions, saponins, immune-stimulating complexes (ISCOMs), liposomes, microparticles, nonionic block copolymers, derivatized polysaccharides, cytokines, and a wide variety of bacterial derivatives. The mechanisms of action of these diverse compounds vary, as does their induction of cell-mediated and antibody responses. Factors influencing the selection of an adjuvant include animal species, specific pathogen, vaccine antigen, route of immunization, and type of immunity needed.

Cite

CITATION STYLE

APA

Spickler, A. R., & Roth, J. A. (2003, May). Adjuvants in Veterinary Vaccines: Modes of Action and Adverse Effects. Journal of Veterinary Internal Medicine. https://doi.org/10.1892/0891-6640(2003)017<0273:AIVVMO>2.3.CO;2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free